166 related articles for article (PubMed ID: 17786848)
1. Biopharmaceuticals and the future of the pharmaceutical industry.
Lowe JA; Jones P
Curr Opin Drug Discov Devel; 2007 Sep; 10(5):513-4. PubMed ID: 17786848
[No Abstract] [Full Text] [Related]
2. Evolution and future of biopharmaceuticals.
Health Aff (Millwood); 2006; 25(5):1270. PubMed ID: 16966722
[No Abstract] [Full Text] [Related]
3. Editorial: biopharmaceutical technologies.
Jungbauer A
Biotechnol J; 2007 Jun; 2(6):647. PubMed ID: 17570696
[No Abstract] [Full Text] [Related]
4. Biopharmaceuticals: recent approvals and likely directions.
Walsh G
Trends Biotechnol; 2005 Nov; 23(11):553-8. PubMed ID: 16051388
[TBL] [Abstract][Full Text] [Related]
5. Manufacturing of biopharmaceuticals and implications for biosimilars.
Wurm FM
Kidney Blood Press Res; 2007; 30 Suppl 1():6-8. PubMed ID: 17726336
[No Abstract] [Full Text] [Related]
6. Insurers' strategies for managing the use and cost of biopharmaceuticals.
Robinson JC
Health Aff (Millwood); 2006; 25(5):1205-17. PubMed ID: 16966716
[TBL] [Abstract][Full Text] [Related]
7. Drug discovery: past, present and future.
Malik NN
Drug Discov Today; 2008 Nov; 13(21-22):909-12. PubMed ID: 18852066
[No Abstract] [Full Text] [Related]
8. Russia through the prism of the world biopharmaceutical market.
Bairamashvili DI; Rabinovich ML
Biotechnol J; 2007 Jul; 2(7):801-17. PubMed ID: 17615600
[TBL] [Abstract][Full Text] [Related]
9. Industry views of biosimilar development in Japan.
Horikawa H; Tsubouchi M; Kawakami K
Health Policy; 2009 Jul; 91(2):189-94. PubMed ID: 19157628
[TBL] [Abstract][Full Text] [Related]
10. Back to the future: driving innovation in drug development.
Wagner JA
Clin Pharmacol Ther; 2008 Feb; 83(2):199-202. PubMed ID: 18202681
[No Abstract] [Full Text] [Related]
11. Does chemistry have a future in therapeutic innovations?
Meunier B
Angew Chem Int Ed Engl; 2012 Aug; 51(35):8702-6. PubMed ID: 22777842
[No Abstract] [Full Text] [Related]
12. A perfect storm for innovation.
Williams RN
Clin Pharmacol Ther; 2010 Jul; 88(1):23; author reply 23-4. PubMed ID: 20445532
[No Abstract] [Full Text] [Related]
13. Biopharma in Piedmont, Italy.
Sakariassen KS
Nat Rev Drug Discov; 2005 Jun; 4(6):519. PubMed ID: 15959953
[No Abstract] [Full Text] [Related]
14. Chinese biotech hamstrung by production issues.
Jia H
Nat Biotechnol; 2007 Feb; 25(2):147-8. PubMed ID: 17287733
[No Abstract] [Full Text] [Related]
15. Where is the optimism? Warrior teachings to regain the drug discovery spirit.
Uitdehaag JC
Drug Discov Today; 2007 Feb; 12(3-4):105-7. PubMed ID: 17275729
[No Abstract] [Full Text] [Related]
16. Pharmaceutical industry.
Weiner M
Pharmacology; 1972; 8(1):201-4. PubMed ID: 4644649
[No Abstract] [Full Text] [Related]
17. The other path for follow-ons.
Nat Biotechnol; 2008 Jul; 26(7):715. PubMed ID: 18612272
[TBL] [Abstract][Full Text] [Related]
18. [Future developments in the pharmaceutical industry].
Kleemann A
Pharm Unserer Zeit; 1996 Nov; 25(6):298-9. PubMed ID: 9082454
[No Abstract] [Full Text] [Related]
19. Building biomanufacturing capacity--the chapter and verse.
Kamarck ME
Nat Biotechnol; 2006 May; 24(5):503-5. PubMed ID: 16680126
[TBL] [Abstract][Full Text] [Related]
20. The farmyard drug store.
Nature; 2006 Sep; 443(7107):16-7. PubMed ID: 16957702
[No Abstract] [Full Text] [Related]
[Next] [New Search]
